European Journal of Surgical Oncology
Volume 36 , Pages S23-S26 , September 2010

Improving quality of cancer care through surgical audit

  • W. van Gijn
  • ,
  • C.J.H. van de Velde

      Affiliations

    • Corresponding Author InformationCorresponding author. Leiden University Medical Center, Department of Surgery, K6-R, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Tel.: +31 71 526 2309; fax: +31 71 526 6750.
  • ,
  • on behalf of the members of the EURECCA consortium

      Affiliations

    • A. Dziki, Medical University of Lodz, PolandE.H. Eddes, Dutch Surgical Colorectal Audit, The NetherlandsS. Laurberg, Danish Colorectal Cancer Database, DenmarkP. Mroczkowski, University of Magdeburg, GermanyH. Ortiz, Universidad Pública de Navarra, SpainL. Pahlman, Swedish Colorectal Cancer Registration, SwedenD. Pavalkis, Kaunas University of Medicine, LithuaniaF. Penninckx, Belgian Cancer Registry [PROCARE], BelgiumG. Romano, National Cancer Institute of Naples, ItalyJ. Smith, National Bowel Cancer Programme, United KingdomV. Valentini, Università Cattolica S. Cuore, Rome, ItalyC.J.H. van de Velde, Leiden University Medical Center, The NetherlandsA. Wibe, Norwegian Colorectal Cancer Registry, Norway.

,Accepted 10 June 2010.

References 

  1. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009;45(6):931–991
  2. Birkmeyer JD, Finlayson EV, Birkmeyer CM. Volume standards for high-risk surgical procedures: potential benefits of the leapfrog initiative. Surgery. 2001;130(3):415–422
  3. McCulloch P. Surgical professionalism in the 21st century. Lancet. 2006;367(9505):177–181
  4. Gatta G, Faivre J, Capocaccia R, et al. Survival of colorectal cancer patients in Europe during the period 1978–1989. Eur J Cancer. 1998;34(14):2176–2183
  5. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence?. Br J Surg. 1982;69(10):613–616
  6. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–1482
  7. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341(8843):457–460
  8. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer – implementation of total mesorectal excision as routine treatment in Norway. A national Audit. Dis Colon Rectum. 2002;45(7):857–866
  9. Wibe A. Nationwide quality Assurance of rectal cancer treatment. In: Colorectal congress. 28th November 2007, St. Gallen, Switzerland; 2007.
  10. Pahlman L, Bohe M, Cedermark B, et al. The Swedish Rectal Cancer Registry. Br J Surg. 2007;94(10):1285–1292
  11. Birgisson H, Talback M, Gunnarsson U, et al. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol. 2005;31(8):845–853
  12. Harling H, Bulow S, Kronborg O, et al. Survival of rectal cancer patients in Denmark during 1994–99. Colorectal Dis. 2004;6(3):153–157
  13. Report of The National Bowel Cancer Audit Programme “NBOCAP Report 2009”. http://www.nbocap.org.uk/resources/reports/NBOCAP_2009.pdf.
  14. Mroczkowski P, Kube R, Schmidt U, et al. Quality assessment of colorectal cancer care – an international online model. Colorectal Dis. 2010;
  15. Penninckx F, Van EL, Michiels G, et al. Survival of rectal cancer patients in Belgium 1997–98 and the potential benefit of a national project. Acta Chir Belg. 2006;106(2):149–157
  16. PROCARE: Global Results. 2009;http://www.coldfusionwebhostings.be/PSK/upload/File/Global_Results.pdf
  17. Spanish TME Project. 2006–2008;http://www.aecirujanos.es/secciones/coloproctologia/proyecto_vikingo_informe_2006-2008.pdf
  18. Dutch Surgical Colorectal Audit: Report. 2009;http://www.dsca.nl/images/documenten/jaarrapportage%20DSCA.pdf

PII: S0748-7983(10)00202-7

doi: 10.1016/j.ejso.2010.06.026

European Journal of Surgical Oncology
Volume 36 , Pages S23-S26 , September 2010